Document is current

Any future updates will be listed below

Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice

Crossref DOI link: https://doi.org/10.1007/s10549-024-07427-2

Published Online: 2024-07-13

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark